Dr Chao-Yu Chen


NAME:                     Chen, Chao-Yu (陳兆瑜)
SEX:             Female
BIRTH DATE:        Oct. 13, 1983
BIRTH PLACE:     Hualian, Taiwan.
CITIZENSHIP:       Taiwan


Dept. of Obstetric & Gynecology, Chang Gung Memorial Hospital
6 West Sec, Chia-Pu Road, Pu-Zi city, Chiayi 613, Taiwan, R.O.C.
Tel: 05-362-1-000 ext. 2592
Fax: 05-362-3002

College of Medicine, Chang Gung University, Taiwan, 2001 – 2008
Degree – Bachelor of Medicine

2008 – 2011 Resident, Dept. of Ob-Gyn, Chang Gung Memorial Hospital at Linkou
2011 – 2012 Chief Resident, Dept. of Ob-Gyn, Chang Gung Memorial Hospital at Linkou
2012 – 2014 Fellow, Division of Gynecologic Oncology, Dept. of Ob-Gyn, Chang Gung Memorial Hospital at Linkou
2014-2015 Attending Physician, Dept. of Ob-Gyn, Chang Gung Memorial Hospital at Chiayi
2015-2017 Lecturer Physician, Dept. of Ob-Gyn, Chang Gung Memorial Hospital at Chiayi
2017-now Assistant Professor, Dept. of Ob-Gyn, Chang Gung Memorial Hospital at Chiayi


Vice Chief of Peritoneal Malignancy Program of Cancer Center, Chang Gung Memorial Hospital at Chiayi
Member of the Asian Peritoneal Surface Malignancy Group (APSMG) Executive Committee
Member, Taiwan Association of Obstetrics and Gynecology (TAOG)
Member, International Gynecologic Cancer Society (IGCS)
Associate member, Taiwan Association of Gynecologic Oncologists (TGOG)
Member, The Taiwanese Osteoporosis Association (TOA)


License of Medical Doctor, Taiwan, No. 042979
Specialty Board of Obstetrics and Gynecology, Taiwan, No. 002963



  1. General obstetric and gynecologic practice
  2. Gynecologic, genital tract cancer surgery and chemotherapy (Cervical Ca, Ovarian Ca, Uterine Ca, Vulva Ca, Vaginal Ca)
  3. Analysis of public administrative health database in gynecologic oncology (Taiwan Cancer Registry, National health insurance research database)
  4. Peritoneal malignancies (Hyperthermic intraperitoneal chemotherapy and cytoreductive surgery)




  1. Chen CY, Chang HP, Ng KK, Wang CC, Lai CH, Chao A*. Long-term disease-free survival in three ovarian cancer patients with a single relapse. Eur J Gynaecol Oncol. 2012;33(3):321-3.
  2. Sicam RV, Huang KG*, Lee CL, Chen CY, Ueng SH. Treatment of fallopian tube metastasis in cervical cancer after laparoscopic ovarian transposition. J Minim Invasive Gynecol. 2012 Mar-Apr;19(2):262-5.
  3. Chen CY, Lai CH, Lee KD, Huang SH, Dai YM, Chen MC*. Risk of second primary malignancies in women with cervical cancer: a population-based study in Taiwan over a 30-year period. Gynecol Oncol. 2012 Dec;127(3):625-30.
  4. Chen CY, Huang KG*, Abdullah NA, Ueng SH, Adlan MOG(Mal) AS, Lee CL. Successful treatment of isolated fibular bone metastasis in a uterine endometrial cancer of clear cell carcinoma. Eur J Gynaecol Oncol. 2013;34(4):347-9.
  5. Lin G#, Chen CY#, Liu FY#, Yang LY, Huang HJ, Huang YT, Jung SM, Chou HH, Lai CH*, Ng KK*. Computed tomography, magnetic resonance imaging and FDG positron emission tomography in the management of vulvar malignancies. Eur Radiol. 2015 May;25(5):1267-78.
  6. Chen CY, Lai CH, Yang LY, Tang YH, Chou HH, Chang CJ, Lin CT*. Immunomodulatory therapy in refractory/recurrent ovarian cancer. Taiwan J Obstet Gynecol. 2015 Apr;54(2):143-9.
  7. Lee K#,Chen CY#, Huang HJ, Wang TY, Teng D, Huang SH, Lai CH*, Chen MC*. Increased risk of second primary malignancies following uterine cancer: a population-based study in Taiwan over a 30-year period. BMC Cancer. 2015 May 11;15(1):393.
  8. Chen MY#,Chou HH#,Liu FY, Chen CY, Lin G, Yang LY, Pan YB, Jung SM, Wu RC, Huang YT, Tsai JC, Yen TC, Lai CH*, Chang TC*. 18F-FDG PET in small-cell cervical cancer: a prospective study with long-term follow-up. Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):663-74.
  9. Wang TY, Chen WM, Yang LY, Chen CY, Chou WC, Chen YY, Chen CC, Lee KD, Lu CH*. Score of liver ultrasonography predicts treatment-related severe neutropenia and neutropenic fever in induction chemotherapy with docetaxel for locally advanced head and neck cancer patients with normal serum transamines. Support Care Cancer. 2016 Nov;24(11):4697-703.

10. Chou HH, Huang HJ, Cheng HH, Chang CJ, Yang LY, Huang CC, Chang WY, Hsueh S, Chao A, Wang CJ, Tang YH, Lin CT, Qiu JT, Chen MY, Chen CY, Huang KG, Tsai TC, Chang TC, Lai CH*. Self-sampling HPV test in women not undergoing Pap smear for more than 5 years and factors associated with under-screening in Taiwan. J Formos Med Assoc. 2016 Dec;115(12):1089-96.

  1. Chen CY, Yang YH, Lee CP, Wang TY, Cheng BH, Huang YC, Chen PC, Liang SH, Dewey M, Chen VC*. Risk of depression following uterine cancer: a nationwide population-based study. Psychooncology. 2017 Nov;26(11):1770-1776.
  2. Chou HH*#, ChenCY#, Liu FY#, Lin G, Wang CC, Yang LY, Chen MY, Pan YB, Wu RC, Ten TC, Chang TC, Lai CH*. Positron emission tomography in the management of documented or suspected recurrent ovarian cancer. J Formos Med Assoc. 2017 Nov;116(11):869-879.

13. Wang TY, Chen CY#, Lu CH, Chen MC, Lee LW, Huang TH, Hsieh MC, Chen CJ, Yu CM, Chuang HC, Liao TT, Tseng CW, Huang WS#. Cytoreductive Surgery with Hyperthermic Intraperitoneal chemotherapy for peritoneal malignancy: preliminary results of a multi-disciplinary teamwork model in Asia. Int J Hyperthermia. 2017 Jun 23:1-8. [Epub ahead of print]